Pacific Biosciences of California, Inc. (PACB): Long-Term Debt
Older than the company's other figures. The latest Long-Term Debt is for the year ended 2022-12-31, while the company's latest annual report covers the year ended 2025-12-31. Its later filings do not report this line under the concept TickerFacts maps.
$896.68M
As of 2022-12-31
n/m
3-year compound annual growth
n/m
5-year compound annual growth
| Period ended | Long-Term Debt | Change YoY | Source filing |
|---|---|---|---|
| 2022-12-31 | $896.68M | +0.1% | 2023-02-28, Balance as of period end |
| 2021-12-31 | $896.07M | n/a | 2022-02-28, Balance as of period end |
| No annual figure between 2019-12-31 and 2021-12-31. | |||
| 2019-12-31 | $15.87M | +8.3% | 2020-02-28, Balance as of period end |
| 2018-12-31 | $14.66M | +7.5% | 2019-02-26, Balance as of period end |
| 2017-12-31 | $13.63M | -15.3% | 2018-02-26, Balance as of period end |
| 2016-12-31 | $16.11M | n/a | 2017-03-06, Balance as of period end |
| No annual figure between 2014-12-31 and 2016-12-31. | |||
| 2014-12-31 | $14.12M | +5.8% | 2015-03-12, Balance as of period end |
| 2013-12-31 | $13.35M | n/a | 2014-03-14, Balance as of period end |